Mitogen Activated Protein Kinases : Functions in Signal Transduction and Human Diseases
| Mitogen Activated Protein Kinases : Functions in Signal Transduction and Human Diseases |
| Autore | Tikkanen Ritva |
| Pubbl/distr/stampa | Basel, Switzerland, : MDPI - Multidisciplinary Digital Publishing Institute, 2020 |
| Descrizione fisica | 1 online resource (276 p.) |
| Soggetto topico |
Biology, life sciences
Research & information: general |
| Soggetto non controllato |
angiogenesis
antimicrobial peptide aortic valve sclerosis aortic valve stenosis apoptosis atherosclerosis bone remodeling bronchopulmonary dysplasia cancer cancer signaling cecropin A cell cycle Compatibility CR cytokines DAPK DOK4 downregulation DUSP1 ERK ERK1/2 erlotinib extracellular signal-regulated kinase 5 (ERK5) extracellular signal-regulated kinases 1/2 FGF-induced signaling FR180204 FRS2 gastric ulcer HPAECs hyperoxia infantile myofibromatosis inflammation JNK JNKs Kv4.2 MAPK MAPK kinetics MAPK/PI3K/Akt signaling pathway MEK/ERK signaling metabolic profiling mitochondria mitochondrial dysfunction mitogen-activated protein kinase pathway (MAPK pathway) mitogen-activated protein kinases (MAPKs) MKK4 MKK7 N-heterocyclic carbene n/a naphthalimide-metal complex conjugates neuro-inflammation neurodegeneration NF-κB osteoclast differentiation oxidative stress p38 p38 MAPK p38 MAPKs p53 Parkinson's disease PC12 cells phosphorylation platelet-derived growth factor receptor porcine intestinal epithelial cell protein kinase inhibitors protein tyrosine phosphatase interacting protein 51 (PTPIP51) protein-protein interaction (PPI) psoriasis PTPN6 Rabdosia inflexa reactive oxygen species receptor tyrosine kinases ROS SIRT1 SIRT2 SR SRC sunitinib T2DM targeted therapy tight junction protein U0126 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Altri titoli varianti | Mitogen Activated Protein Kinases |
| Record Nr. | UNINA-9910557405603321 |
Tikkanen Ritva
|
||
| Basel, Switzerland, : MDPI - Multidisciplinary Digital Publishing Institute, 2020 | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Molecular Pathways in Cancers
| Molecular Pathways in Cancers |
| Autore | Cristóbal Ion |
| Pubbl/distr/stampa | Basel, : MDPI - Multidisciplinary Digital Publishing Institute, 2022 |
| Descrizione fisica | 1 online resource (284 p.) |
| Soggetto topico |
Medicine and Nursing
Oncology |
| Soggetto non controllato |
acetylation
actin cytoskeletal reorganization adaptive immunity advanced ovarian cancer anti-receptor therapy BET inhibitors biomarkers bladder cancer initiation breast cancer CALR cancer cancer immunology cancer therapeutics carcinogenicity CD99 agonist complement system DUSP1 EGFR dimerization endocytosis epigenetic epigenome epithelial cells FAK dephosphorylation genome glioblastoma gp120 hepatocellular carcinoma human immunodeficiency virus type 1 immune checkpoint inhibitors immune evasion immunotherapy innate immunity JAK2 luminal breast cancer MAPK matrix protein p17 metastasis metastatic melanoma methylation migration and invasion mitochondria molecular targeted agents MPL MS-determined phosphopeptides mTOR myeloproliferative neoplasms n/a Nef NIMA-related kinase 1 (NEK1) non-coding RNA OMD oncogenic signaling pathway ovarian cancer oxidative stress OXPHOS pancreatic ductal adenocarcinoma partial EMT patient survival pBRD4 PI3K PP2A PRELP prognosis prostate cancer PTPN12 Rac1 reactive oxygen species resistance reverse transcriptase RhoA SET signaling pathways small-cell lung cancer Snail splicing pathway TAK-228 Tat thioridazine (THD) tight junction tousled-like kinase (TLK) TPOR trastuzumab tripeptide triple negative breast cancer triple-negative breast cancer tumor immune microenvironment tumor microenvironment tumor suppression gene Warburg effect yes-associated protein 1 (YAP1) |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Record Nr. | UNINA-9910566473703321 |
Cristóbal Ion
|
||
| Basel, : MDPI - Multidisciplinary Digital Publishing Institute, 2022 | ||
| Lo trovi qui: Univ. Federico II | ||
| ||